Bowhead Specialty Holdings Files Supplemental Proxy for Merger
Bowhead Specialty Holdings has filed a supplemental proxy statement for its merger with American Family Mutual Insurance Company, clarifying key details for stockholders.
UnitedHealth Group registers $200 million in executive savings plan
UnitedHealth Group files to register an additional $200 million in deferred compensation obligations under its OptumCare Executive Savings Plan.
StoneX Group reports $2.7B in securities holdings in 13F-HR
StoneX Group Inc. files 13F-HR, revealing $2.7B in securities holdings, reflecting its investment strategy in the Security & Commodity Brokers sector.
Bank of Montreal Registers $1.93 Million in New Notes
Bank of Montreal has filed a registration for $1.93 million in senior medium-term notes, indicating a strategic funding move in the commercial banking sector.
Sara Bonstein sells shares of INSMED Inc to meet tax obligations
Sara Bonstein sold 10,261 shares of INSMED Inc to satisfy tax obligations. The sale highlights trends in stock compensation in the pharmaceutical industry.
Buckhead Capital Management reports $289M portfolio value
Buckhead Capital Management LLC reveals a portfolio worth $289 million in its latest 13F-HR filing, focusing on major tech and consumer stocks.
GS Finance Corp. files for $2.7 million note offering
GS Finance Corp. has filed a registration statement for $2.7 million in autocallable contingent coupon index-linked notes, showcasing innovation in the industry.
Royal Bank of Canada launches new Auto-Callable Notes
Royal Bank of Canada files for Auto-Callable Enhanced Return Notes linked to Alphabet and Meta, expanding its offerings in the commercial banking sector.
GS Finance Corp. Files Pricing Supplement for Medium-Term Notes
GS Finance Corp. files a pricing supplement for Medium-Term Notes linked to Bloom Energy and Generac Holdings, signaling a strategic market move.
Bank of Montreal Announces $2.34 Million Callable Notes
Bank of Montreal files for $2.34 million in callable notes linked to major indices, signaling innovation in commercial banking products.
Mackenzie Financial Corp increases stake in CAE Inc. to 2.4%
Mackenzie Financial Corp has increased its stake in CAE Inc. to 2.4%, indicating growing interest in the electrical machinery sector.
Michael Vasconcelles Reports Share Ownership in MacroGenics
Michael Vasconcelles files Form 3, reporting share ownership in MacroGenics Inc., highlighting his role as a director in the pharmaceutical industry.
Cable One, Inc. Reports Change in Ownership by Director
Cable One, Inc. has filed a report detailing a change in ownership involving director Paul Keglevic, highlighting industry transparency.
REGENXBIO's Chief Strategy Officer Acquires 34,722 Shares
REGENXBIO Inc.'s Chief Strategy & Legal Officer, Patrick J. Christmas, acquires 34,722 shares, signaling ongoing executive compensation strategies.
Kuriakose Emil reports stock option and RSU transactions
Kuriakose Emil disclosed stock option and restricted stock unit transactions, reflecting its commitment to employee incentives in the pharmaceutical industry.
XCF Global CEO Receives Major Restricted Stock Grant
Cooper Christopher Arnold, CEO of XCF Global, Inc., awarded significant restricted stock as part of his employment agreement, signaling confidence in the company's future.
Hilton's Marissa Mayer Acquires 175 Shares of Common Stock
Marissa Mayer, director at Hilton, acquires 175 shares of common stock, raising her total holdings. This reflects confidence in the hospitality sector.
Malzahn Craig Reports Stock Transaction as CTO of REGENXBIO
Malzahn Craig, CTO of REGENXBIO, reports a stock transaction involving 27,777 shares, indicating continued commitment to the company and industry trends.
Falconi Campos Vicente Reports Major Share Transactions
Falconi Campos Vicente discloses significant share transactions involving AXIA Energia S.A., impacting the electric services sector in Brazil.
Vasconcelles reports stock option and RSU transactions
Michael Vasconcelles reports significant stock option and RSU transactions with MacroGenics, reflecting ongoing confidence in the pharmaceutical sector.